Related Parties and Related-Party Transactions

12 Months Ended

Dec. 31, 2021

Related Party Transactions [Abstract]

Related Parties and Related-Party Transactions

12.Related Parties and Related-Party Transactions

On October 16, 2014, the Company entered into a collaboration agreement with Adimab, LLC. The Company’s co-founder and former chief operation officer has a direct ownership interest in Adimab, LLC and previously beneficially owned more than 5% of the Company’s common stock. He does not currently beneficially own more than 5% of the Company's common stock. The Company did not record any expenses in connection with this agreement during years ended December 31, 2021 and 2020.

On June 25, 2021, the Company and Miranda Toledano, a director of the Company, entered into a Consulting Agreement, pursuant to which Ms. Toledano was to provide, for a period of six months, consulting services to the Company. Ms. Toledano was entitled to consulting fees of $20,000 per month. As of December 31, 2021, the full amount of the agreement has been paid and the agreement has terminated.